StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)

Close on Nov 18, 2026Market cap $1.41BP/E –Yield –

uniQure total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

uniQure's total debt was $50.15M at Jun 30, 2026. For fiscal 2025 it was $49.70M, down 3.2% from the year before. Over ten years it grew 9.4% a year on average. The highest annual figure on record is $102.79M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$49.70M-3.2%
FY2024Dec 31, 2024$51.32M-49.6%
FY2023Dec 31, 2023$101.75M-1.0%
FY2022Dec 31, 2022$102.79M+1.8%
FY2021Dec 31, 2021$100.96M+183.5%
FY2020Dec 31, 2020$35.62M-1.2%
FY2019Dec 31, 2019$36.06M+1.7%
FY2018Dec 31, 2018$35.47M+70.6%
FY2017Dec 31, 2017$20.79M+2.7%
FY2016Dec 31, 2016$20.24M+0.1%
FY2015Dec 31, 2015$20.21M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$50.15M-3.3%
Q1 FY2026Mar 31, 2026$49.94M-3.2%
Q4 FY2025Dec 31, 2025$49.70M-3.2%
Q3 FY2025Sep 30, 2025$51.88M+1.5%
Q2 FY2025Jun 30, 2025$51.84M-49.4%
Q1 FY2025Mar 31, 2025$51.59M-49.5%
Q4 FY2024Dec 31, 2024$51.32M-49.6%
Q3 FY2024Sep 30, 2024$51.11M-49.6%
Q2 FY2024Jun 30, 2024$102.51M+1.4%
Q1 FY2024Mar 31, 2024$102.12M-1.1%
Q4 FY2023Dec 31, 2023$101.75M-1.0%
Q3 FY2023Sep 30, 2023$101.43M-0.9%
Q2 FY2023Jun 30, 2023$101.11M-0.8%
Q1 FY2023Mar 31, 2023$103.25M+1.8%
Q4 FY2022Dec 31, 2022$102.79M+1.8%
Q3 FY2022Sep 30, 2022$102.39M+43.2%
Q2 FY2022Jun 30, 2022$101.89M+44.0%
Q1 FY2022Mar 31, 2022$101.42M+43.9%
Q4 FY2021Dec 31, 2021$100.96M+183.5%
Q3 FY2021Sep 30, 2021$71.49M+101.4%
Q2 FY2021Jun 30, 2021$70.78M+100.1%
Q1 FY2021Mar 31, 2021$70.47M+94.6%
Q4 FY2020Dec 31, 2020$35.62M-1.2%
Q3 FY2020Sep 30, 2020$35.49M-1.2%
Q2 FY2020Jun 30, 2020$35.37M-1.1%
Q1 FY2020Mar 31, 2020$36.21M+1.6%
Q4 FY2019Dec 31, 2019$36.06M+1.7%
Q3 FY2019Sep 30, 2019$35.93M+73.5%
Q2 FY2019Jun 30, 2019$35.78M+71.5%
Q1 FY2019Mar 31, 2019$35.63M+71.2%
Q4 FY2018Dec 31, 2018$35.47M+70.6%
Q3 FY2018Sep 30, 2018$20.71M+0.6%
Q2 FY2018Jun 30, 2018$20.87M+1.9%
Q1 FY2018Mar 31, 2018$20.81M+2.2%
Q4 FY2017Dec 31, 2017$20.79M+2.7%
Q3 FY2017Sep 30, 2017$20.59M–
Q2 FY2017Jun 30, 2017$20.47M–
Q1 FY2017Mar 31, 2017$20.36M–
Q4 FY2016Dec 31, 2016$20.24M–

More uniQure figures

See a number that looks wrong?